Camlin Fine Sciences Q4 FY26 Preview: Revenue Growth Expectations and Earnings Outlook

Camlin Fine Sciences Q4 FY26 results date is all set to be announced soon and most investors are awaiting it. Professionals are expecting an increase in revenue due to higher sales and a significant rise in PAT. Camlin Fine Sciences was listed on the National Stock Exchange (NSE) on 20-Jan-1995. Camlin Fine Sciences share has its face value of 1 per share, and its NSE symbol is CAMLINFINE. The company operates in the Chemicals sector and primarily belongs to the Specialty Chemicals industry.

Camlin Fine Sciences Q4 Results 2026 Preview

• Camlin Fine Sciences Q4 FY26 revenue is expected to be around Strong Growth, representing a 14% YoY increase compared to the same quarter last year.
• Profit After Tax, or PAT, is projected to rise 15% YoY.
• EBITDA to rise 13%.
• Camlin Fine Sciences is expected to show Strong Growth in its revenue. 

Click and Sign Up to Get Live Updates on Q4 Results

Camlin Fine Sciences Share Performance

• Over the past six months, Camlin Fine Sciences share price has positive by 10% to 131.61.
• Moreover, over the past year, the stock has positive by 24%
• Despite this weak short-term performance, Camlin Fine Sciences stock has delivered a financially sound 168% return over the past 5 years.
• As of today, 13-03-2026, the Camlin Fine Sciences share price is trading at 131.61 per share.

Key Factors to Watch for Camlin Fine Sciences Q4 Results FY26

• Revenue Growth & Segment Performance – Focus on topline growth in the Specialty Chemicals industry within the Chemicals sector.
• Occupancy Levels & Seat Expansion – Monitor operational expansion and capacity utilisation trends.
• Profitability & Margin Trends – Track EBITDA and PAT margins to evaluate cost control and operating efficiency.
• Order Book & New Client Wins – Watch for updates on new contracts, partnerships, and long-term deals.
• Balance Sheet & Cash Flow Position – Review debt levels, working capital management, and operating cash flows for financial stability.

About Camlin Fine Sciences

Camlin Fine Sciences manufactures specialty chemicals and food antioxidants used in food preservation and industrial applications. The company focuses on expanding specialty chemical products and strengthening export markets.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Final Thoughts

Camlin Fine Sciences is gear up to announce its Q4 FY26 results. Analysts expect 14% revenue growth, a 15% rise in PAT, and a 13% rise in EBITDA. Camlin Fine Sciences focuses on revenue growth from order execution, margin improvement, a strong order book, and management.

Stay informed with Univest blogs to get real-time updates on Camlin Fine Sciences Q4 results FY26. 

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Recent Articles

BASF India Q4 FY26 Results Preview: Revenue, PAT & EBITDA Growth Expectations

Bansal Wire Industries Q4 FY26 Results Preview: Revenue, PAT & EBITDA Growth Expectations

Banswara Syntex Q4 FY26 Results Preview: Revenue, PAT & EBITDA Growth Expectations

Bank of India Q4 FY26 Results Preview: Revenue, PAT & EBITDA Growth Expectations

Bank of Baroda Q4 FY26 Results Preview: Revenue, PAT & EBITDA Growth Expectations